BSc Biomedical Sciences student, Nisha Aziz, was part of a team of researchers at Queen Mary who successfully demonstrated the use of a novel light emitting technology in identifying anti-drug antibodies that can reduce effectiveness of monoclonal antibody therapies. We caught up her to find out more.
Name: Nisha Aziz
Course: BSc Biomedical Sciences
I was involved in preparing the reagents and testing out the different methods for the assay.
I gained many skills from undertaking this project including critical thinking which involved identifying problems and investigating why an issue arose.
I think that with rapid improvements in technology, this assay has the potential to be further developed into a test that could be used in point of care testing.
This project has taught me that persistence is key in research as we had to trial multiple methods before we ended up with the final functioning assay.
I am currently in the process of applying to the NHS STP programme, which requires certain research skills that I am now able to fulfil due to the skills I gained from undertaking the research project.
New light technology helps identify anti-drug antibodies